ID

12810

Descripción

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT01744223

Link

https://clinicaltrials.gov/show/NCT01744223

Palabras clave

Versiones (1)
  1. 21/12/15 21/12/15 -
Subido en

21 de diciembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Lymphoblastic Leukemia NCT01744223

Inglés

Eligibility Acute Lymphoblastic Leukemia NCT01744223

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
lack of suitable conventional donor (i.e. 7/8 or 8/8 related or 7/8 or 8/8 unrelated donor) or presence of rapidly progressive disease not permitting time to identify an unrelated donor
Descripción

lack of suitable stem cell donor or rapidly progressive disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0375877
UMLS CUI [2]
C0677932
hla typing will be performed at high resolution (allele level) for the hla-a, -b, cw, and drbl, and loci. a minimum match of 5/10 is required. the donor and recipient must be identical, as determined by high resolution typing, at least one allele of each of the following genetic loci: hla-a, hla-b, hla-cw, and hla- drb1.
Descripción

hla typing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242318
subjects with adequate physical function as measured by:a)cardiac: left ventricular ejection fraction at rest must be >35 percent, or shortening fraction > 25percent. b)hepatic: bilirubin < 2.5 mg/dl; and alt, ast, and alkaline phosphatase < 5 x uln. c)renal: serum creatinine within normal range for age, or creatinine clearance or gfr > 40 ml/min/1.73m2. d)pulmonary: fev 1, fvc, dlco (diffusion capacity) > 50 percent predicted (corrected for hemoglobin); or 02 saturation > 92 percent on room air.
Descripción

adequate physical function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0231162
clinical diagnosis of one of the following: acute lymphoblastic leukemia, acute myelogenous leukemia, lymphoma
Descripción

acute lymphoblastic leukemia, acute myelogenous leukemia, lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023449
UMLS CUI [2]
C0023467
UMLS CUI [3]
C0024299
subjects must have received cytotoxic chemotherapy within 3 months of consent date (measured from the start date of chemotherapy).
Descripción

chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
performance status: karnofsky/lansky score > 60 percent.
Descripción

karnofsky performance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
hla-matched, related or 7-or 8/8 allele matched (hla-a,-b,-cw,-drbl) unrelated donor able to donate.
Descripción

stem cell donor available

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0375877
UMLS CUI [1,2]
C0470187
autologous hematopoietic stem cell transplant < 3 months prior to enrollment.
Descripción

autologous hematopoietic stem cell transplant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1831743
pregnancy or breast-feeding.
Descripción

pregnant or breastfeeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0006147
evidence of hiv infection or known hiv positive serology.
Descripción

hiv positivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
current uncontrolled bacterial, viral or fungal infection (currently taking medication with evidence of progression of clinical symptoms or radiologic findings).
Descripción

current uncontrolled bacterial, viral or fungal infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004623
UMLS CUI [2]
C0042769
UMLS CUI [3]
C0026946
non-hematologic malignancy within prior three (3) years.
Descripción

non-hematologic malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0935681
prior allogeneic hematopoietic stem cell transplant.
Descripción

allogeneic hematopoietic stem cell transplant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2242529
subjects with a history of primary idiopathic myelofibrosis.
Descripción

idiopathic myelofibrosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001815
bovine product allergy.
Descripción

bovine product allergy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020517
UMLS CUI [2]
C0036774
Volver a la parte superior de la página

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT01744223

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
lack of suitable stem cell donor or rapidly progressive disease
Item
lack of suitable conventional donor (i.e. 7/8 or 8/8 related or 7/8 or 8/8 unrelated donor) or presence of rapidly progressive disease not permitting time to identify an unrelated donor
boolean
C0375877 (UMLS CUI [1])
C0677932 (UMLS CUI [2])
hla typing
Item
hla typing will be performed at high resolution (allele level) for the hla-a, -b, cw, and drbl, and loci. a minimum match of 5/10 is required. the donor and recipient must be identical, as determined by high resolution typing, at least one allele of each of the following genetic loci: hla-a, hla-b, hla-cw, and hla- drb1.
boolean
C0242318 (UMLS CUI [1])
adequate physical function
Item
subjects with adequate physical function as measured by:a)cardiac: left ventricular ejection fraction at rest must be >35 percent, or shortening fraction > 25percent. b)hepatic: bilirubin < 2.5 mg/dl; and alt, ast, and alkaline phosphatase < 5 x uln. c)renal: serum creatinine within normal range for age, or creatinine clearance or gfr > 40 ml/min/1.73m2. d)pulmonary: fev 1, fvc, dlco (diffusion capacity) > 50 percent predicted (corrected for hemoglobin); or 02 saturation > 92 percent on room air.
boolean
C0231162 (UMLS CUI [1])
acute lymphoblastic leukemia, acute myelogenous leukemia, lymphoma
Item
clinical diagnosis of one of the following: acute lymphoblastic leukemia, acute myelogenous leukemia, lymphoma
boolean
C0023449 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
chemotherapy
Item
subjects must have received cytotoxic chemotherapy within 3 months of consent date (measured from the start date of chemotherapy).
boolean
C0392920 (UMLS CUI [1])
karnofsky performance
Item
performance status: karnofsky/lansky score > 60 percent.
boolean
C0206065 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
stem cell donor available
Item
hla-matched, related or 7-or 8/8 allele matched (hla-a,-b,-cw,-drbl) unrelated donor able to donate.
boolean
C0375877 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
autologous hematopoietic stem cell transplant
Item
autologous hematopoietic stem cell transplant < 3 months prior to enrollment.
boolean
C1831743 (UMLS CUI [1])
pregnant or breastfeeding
Item
pregnancy or breast-feeding.
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
hiv positivity
Item
evidence of hiv infection or known hiv positive serology.
boolean
C0019699 (UMLS CUI [1])
current uncontrolled bacterial, viral or fungal infection
Item
current uncontrolled bacterial, viral or fungal infection (currently taking medication with evidence of progression of clinical symptoms or radiologic findings).
boolean
C0004623 (UMLS CUI [1])
C0042769 (UMLS CUI [2])
C0026946 (UMLS CUI [3])
non-hematologic malignancy
Item
non-hematologic malignancy within prior three (3) years.
boolean
C0935681 (UMLS CUI [1])
allogeneic hematopoietic stem cell transplant
Item
prior allogeneic hematopoietic stem cell transplant.
boolean
C2242529 (UMLS CUI [1])
idiopathic myelofibrosis
Item
subjects with a history of primary idiopathic myelofibrosis.
boolean
C0001815 (UMLS CUI [1])
bovine product allergy
Item
bovine product allergy.
boolean
C0020517 (UMLS CUI [1])
C0036774 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial